Objectives: HIV-positive women have higher human papillomavirus (HPV) prevalence and cervical cancer (CC) incidence than HIV-negative women, partly due to HIV's modifying effect on HPV pathogenesis. We synthesized the literature on the impact of HIV on HPV natural history.
Introduction 100-cell increase in CD4 (OR 0.82, 95% CI 0.70-0.96) [23] . Two studies found higher CD4 count did not significantly reduce HPV incidence (Appendix Table 3, http://links.lww.com/QAD/B224) [25, 26] .
ART
Three of the four studies that ascertained ART use from medical records or self-reports found no association between ART and HPV incidence (Appendix Table  3 ,
http://links.lww.com/QAD/B224) [25, 28, 30] ; while one study found ART reduced HPV16 and 18
incidence by 72% (RR 0.28, 95% CI 0.09-0.86) but not any HPV incidence (RR 0.79, 95% CI 0.28-2.23) [24] . One study comparing effective ART (defined as reducing HIV VLby >90% or to undetectable), to no treatment found that effective ART decreased incidence of any HPV by 36% (OR 0.64, 95% CI 0.46-0.88) but the impact on HR HPV incidence was not statistically significant (OR 0.62, 95% CI 0.38-1.02) [27] .
HIV VL
Two studies evaluated the role of HIV VL on HPV acquisition [5, 26] . Compared to HIVnegative women, the risk of any HPV infection was 3.29times (95% CI 2.18-4.95) higher among HIV-positive women with VL>10,000 copies/mL and 2.31 times (95% CI 1.49-3.58) higher among those with VL<10,000 copies/mL [26] . Further, HPV acquisition was higher with increasing VLamong women with CD4 >200 cells/mm 3 ( Figure 2b ), although no pattern in HPV acquisition by VL was observed in women with CD4 <200 cells/mm 3 [5] .
HPV Reactivation
One study found that new HPV infections were detectedin women who reported no sexual activity in the last 18 months, indicating potential reactivation of latent infections. The rate of
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
potential reactivations was 1.4-4.4 times higher among HIV-positive compared to HIV-negative women [5] .
HPV persistence and clearance
Two studies evaluated clearance among women with incident HPV infection [5, 32] . Table 5 Table 9 , http://links.lww.com/QAD/B224) [4] .
Discussion
HIV infection was associated with higher incidence of and reduced clearance of HPV infection.
Women with low CD4 count and high HIV VL had elevated risk of HPV acquisition, but risk was reduced among ART-adherent women. Low CD4 count was also associated with decreased HPV clearance. While ART reduced LSIL incidence, its impact on HSIL incidence depended on the duration of use. HIV-positive women have lower likelihood of LSIL regression, and ART and high CD4 count were associated with increased LSIL regression. In contrast, HSIL regression was not associated with HIV status. However, the study that examined HSIL regression had a small sample size and should be interpreted with caution.
While the relative risk of acquiring HPV 16/18 was higher among HIV-positive women, HPV 16/18 clearance was not foundto differ by HIV status. This may be due to a lack of power or it may be that HPV 16 and 18 are better at evading the host immune system and are less impacted by HIV-associated immunosuppression [56, 57] . Studies have found that HPV 16 in particular is more weakly associated with the immune system compared to other types [58, 59] . This is populations with impaired immune system [62] [63] [64] [65] . A meta-analysis of cancer incidence in HIVpositive persons and transplant recipients found both groups were at higher risk of cancers with infectious etiology compared to the general population [65] . The destruction of CD4 cells by HIV may increase the likelihood of HPV establishing infection [66] . Recent evidence also suggests that immunosuppression leads to higher probability of HPV reactivation, potentially due to incomplete clearance of HPV DNA [67] . women who were on ART likely already had more advanced HIV disease at treatment initiation.
Studies show that HIV disease state at ART initiation significantly impactsmorbidity and mortality [68] [69] [70] . Further, many studies finding no association approximated ART use with medical records or self-report. Studies using more accurate measures of ART adherence (e.g. viral suppression), found ART reduces HPV disease progression. One study found significantly lower incidence of HPV infection and cervical lesions in women who were virologically suppressed on ART compared to women who not on ART or not virologically suppressed [27] .
A study showed CC cases had higher odds of CD4 decline on ART prior to CC diagnosis compared to controls who did not subsequently develop CC, which may indicate a disruption in ART use prior to the development of CC [71] . A longer duration on ART is also associated with reduced HSIL incidence [4, 47] , which may indicate immune system recovery [72] .
In addition to the limitations of including studies that ascertained ART status through self-reports and chart reviews, another potential limitation of this review is the heterogeneity of studies included. While majority of studies were longitudinal, variation in analysis, effect measures, and exposures definition limited our ability to perform quantitative analysis. Additionally, due to small number of studies eligible for some objectives, we could not use I 2 to quantifyheterogeneity in many cases. High loss to follow up was an issue for some of the studies we included. While this limitation was ameliorated with survival analysis methods that censored individuals lost to follow up, effect estimates may be biased in studies that did not address this limitation in their analysis. The magnitude and direction of bias would depend on whether the lost to follow up was differential by HIV, ART, CD4 or VL status.
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